MedPath

Embryo Selection Using Non-invasive Metabolomic Analysis Versus Morphology

Phase 4
Completed
Conditions
Embryo Viability
Interventions
Other: morphological evaluation
Procedure: non-invasive metabolomic profiling
Registration Number
NCT01490515
Lead Sponsor
Eugonia
Brief Summary

Metabolomics was recently introduced in human IVF for non-invasive identification of viable embryos with the highest developmental competence. The investigators intended to investigate if embryo assessment using non-invasive metabolomic profiling leads to increased implantation rates compared to routine morphology evaluation alone.

Detailed Description

Metabolomics was recently introduced in human IVF for non-invasive identification of viable embryos with the highest developmental competence. The aim of the present study was to determine whether embryo selection using non-invasive metabolomic profiling as an adjunct to morphology leads to increased implantation rates compared to routine morphology evaluation alone.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
125
Inclusion Criteria
  • patients with at least 4 fertilized oocytes
Exclusion Criteria
  • patients with less that 4 fertilized oocytes

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Morphology embryo evaluationmorphological evaluationTo compare non-invasive metabolomic profiling and the traditional method of morphology assessment for embryo selection in terms of implantation and pregnancy rates in a clinical IVF program.
non-invasive metabolomic profilingnon-invasive metabolomic profilingTo compare non-invasive metabolomic profiling and the traditional method of morphology assessment for embryo selection in terms of implantation and pregnancy rates in a clinical IVF program.
Primary Outcome Measures
NameTimeMethod
Implantation rates6 weeks of pregnancy

To compare non-invasive metabolomic profiling and the traditional method of morphology assessment for embryo selection in terms of implantation and pregnancy rates in a clinical IVF program.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Eugonia ART Unit

🇬🇷

Athens, Attiki, Greece

© Copyright 2025. All Rights Reserved by MedPath